UBS Raises DuPont de Nemours Price Target to $87, Maintains "Buy" Rating

UBS analyst Joshua Spector raised the price target for DuPont de Nemours (DD) to $87.00, a 2.35% increase from the previous target of $85.00. The analyst maintains a "Buy" rating and the company is listed on the NYSE under the currency USD. The average target price from 14 analysts is $85.58, indicating a 14.36% upside from the current price of $74.83. The estimated GF Value for DuPont de Nemours in one year is $86.02, suggesting a 14.95% upside from the current price.

UBS analyst Joshua Spector has revised the price target for DuPont de Nemours (DD) to $87.00, a 2.35% increase from the previous target of $85.00. The analyst maintains a "Buy" rating for the company, which is listed on the NYSE under the currency USD [1]. This upward adjustment reflects UBS's continued confidence in DuPont de Nemours' potential performance.

The average target price from 14 analysts is $85.58, indicating a 14.36% upside from the current price of $74.83. Additionally, the estimated GF Value for DuPont de Nemours in one year is $86.02, suggesting a 14.95% upside from the current price [1].

DuPont de Nemours, Inc. provides technology-based materials and solutions in various sectors, including electronics, water protection, and industrial materials. The company's strong financial performance, reflected in its recent earnings report, and its strategic initiatives, such as the spinoff of its electronics division, have contributed to its positive outlook [2].

The company's recent Form 13F filing with the SEC shows that Principal Financial Group Inc. has boosted its stake in DuPont de Nemours by 4.2% in the first quarter. This increase, along with other institutional investors' purchases, underscores the growing confidence in the company's prospects [2].

DuPont de Nemours' recent earnings report highlighted its strong financial performance, with earnings per share (EPS) of $1.03 for the quarter, exceeding analysts' consensus estimates by $0.08. The company's revenue for the quarter was $3.07 billion, up 4.6% compared to the same quarter last year. Additionally, the company declared a quarterly dividend of $0.41 per share, representing a $1.64 annualized dividend and a dividend yield of 2.25% [2].

The company's strong financial performance and strategic initiatives have attracted the attention of several analysts. While some have maintained their positive outlook, others have adjusted their price targets and ratings. For instance, Citigroup increased its price target from $75.00 to $85.00, giving the company a "buy" rating, while Barclays dropped its price objective from $89.00 to $73.00 and set an "equal weight" rating [2].

In summary, UBS's upward revision of the price target for DuPont de Nemours reflects the company's strong financial performance and strategic initiatives. The company's positive outlook is further supported by the growing confidence of institutional investors and the consensus of analysts. Investors are encouraged to consider this revised target in their investment strategies.

References:

[1] https://www.gurufocus.com/news/2967149/dupont-de-nemours-dd-price-target-raised-by-ubs-dd-stock-news
[2] https://www.marketbeat.com/instant-alerts/filing-principal-financial-group-inc-raises-stake-in-dupont-de-nemours-inc-nysedd-2025-07-08/